T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ryanair
RYAAY
$30.8B
| $95.9M | 0.02% |
3,500,852
-116,790
| -3% | -$3.12M |
|
627
McGrath RentCorp
MGRC
$2.94B
| $95.8M | 0.02% |
2,911,057
-157,983
| -5% | -$5.06M |
|
628
Chord Energy
CHRD
$7.53B
| $95.5M | 0.02% |
6,719,336
-751,020
| -10% | -$11M |
|
629
VF Corp
VFC
$5.73B
| $95.3M | 0.02% |
1,344,071
+17,886
| +1% | +$1.24M |
|
630
SPS Commerce
SPSC
$2.75B
| $95.3M | 0.02% |
2,840,254
+207,454
| +8% | +$6.62M |
|
|
XOOM
631
DELISTED
XOOM CORP COM
XOOM
| $95.3M | 0.02% |
6,484,080
+41,370
| +0.6% | +$649K |
|
|
CHS
632
DELISTED
Chicos FAS, Inc.
CHS
| $95.2M | 0.02% |
5,383,930
+18,010
| +0.3% | +$313K |
|
|
SGEN
633
DELISTED
Seagen Inc. Common Stock
SGEN
| $95.1M | 0.02% |
2,689,572
+1,202,218
| +81% | +$41M |
|
634
Petrobras Class A
PBR.A
$103B
| $95M | 0.02% |
15,600,979
-1,443,800
| -8% | -$9.39M |
|
635
Littelfuse
LFUS
$11.7B
| $95M | 0.02% |
955,850
-11,330
| -1% | -$1.11M |
|
|
ECOL
636
DELISTED
US Ecology, Inc.
ECOL
| $94.9M | 0.02% |
1,899,996
-553,800
| -23% | -$25.1M |
|
637
Ionis Pharmaceuticals
IONS
$9.39B
| $94.8M | 0.02% |
1,489,258
-1,189,120
| -44% | -$80.7M |
|
638
Kirby Corp
KEX
$7.18B
| $94.3M | 0.02% |
1,256,882
+111,220
| +10% | +$8.58M |
|
639
Alexandria Real Estate Equities
ARE
$8.27B
| $93.1M | 0.02% |
949,866
-35,680
| -4% | -$3.44M |
|
|
ANN
640
DELISTED
ANN INC
ANN
| $92.7M | 0.02% |
2,259,765
-199,930
| -8% | -$7.31M |
|
641
W.W. Grainger
GWW
$61.5B
| $92.7M | 0.02% |
392,918
+5,816
| +2% | +$1.39M |
|
642
Constellium
CSTM
$4B
| $92.6M | 0.02% |
4,559,301
+53,410
| +1% | +$1M |
|
|
FNSR
643
DELISTED
Finisar Corp
FNSR
| $92.3M | 0.02% |
4,323,817
+304,729
| +8% | +$6.2M |
|
644
Worthington Enterprises
WOR
$2.78B
| $92.1M | 0.02% |
5,616,652
+334,765
| +6% | +$5.75M |
|
|
ININ
645
DELISTED
Interactive Intelligence Group, inc.
ININ
| $91.7M | 0.02% |
2,226,934
+41,770
| +2% | +$1.77M |
|
|
PCL
646
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $90.9M | 0.02% |
2,093,085
-430
| -0% | -$18.7K |
|
|
BECN
647
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $90.8M | 0.02% |
2,900,070
-2,278,880
| -44% | -$62.5M |
|
648
Jack in the Box
JACK
$358M
| $90.4M | 0.02% |
942,690
-230,110
| -20% | -$20.9M |
|
|
ONCE
649
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $90.4M | 0.02% |
+1,204,526
| New | +$69.4M |
|
|
LHO
650
DELISTED
LaSalle Hotel Properties
LHO
| $90.3M | 0.02% |
2,322,977
-19,540
| -0.8% | -$788K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.